🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the Phase 1 part of the study is to determine the maximum to...
Status
Terminated
Location
California Cancer Associates For Research and Exellence, cCare
Start Date
2014-07-30
Trial ID
NCT01999335
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of ixazomi...
Status
Unknown
Location
PekingUMCH
Start Date
2021-07-26
Trial ID
NCT04989140
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose and ef...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2008-06
Trial ID
NCT00833833
Treatments Being Tested
Primary Purpose Phase Ib. To determine the Maximum Tolerated Dose (MTD) and...
Status
Recruiting
Location
West China Hospital Sichuan University
Start Date
2024-03-25
Trial ID
NCT06484829
Treatments Being Tested
This is a single-center, non-randomized, phase 2 study in which patients wi...
Status
Active Not Recruiting
Location
Weill Cornell Medicine - Multiple Myeloma Center
Start Date
2021-10-28
Trial ID
NCT04302324
Treatments Being Tested
The purpose of this study is to see if the study drug, called Vactosertib, ...
Status
Completed
Location
University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Start Date
2017-07-21
Trial ID
NCT03143985
Treatments Being Tested
The main aim is to show that long-term use of ixazomib can improve symptoms...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-06-30
Trial ID
NCT05183139
Treatments Being Tested
This study will independently assess the efficacy and safety of 11 combinat...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2015-10
Trial ID
NCT02343042
This was an open-label, multicenter study designed to evaluate the safety a...
Status
Terminated
Location
John B. Amos Cancer Center - C /ID# 202055
Start Date
2018-10-18
Trial ID
NCT03567616
Treatments Being Tested
The purpose of this study is to evaluate how well IBI3003 works when compar...
Status
Not Yet Recruiting
Location
ZhongShan Hospital FuDan University
Start Date
2026-06-05
Trial ID
NCT07623798